查詢結果
共有 23 筆符合條件的資料
| 序號 | 篇名 | 作者 | 日期 | 期刊 |
|---|---|---|---|---|
| 1 | 從SARS到COVID-19看臺灣於藥品專利強授權之進程 The Development of Compulsory Licensing of Medicine from SARS to COVID-19 in Taiwan: An Expectation to the Legal State |
張哲倫 | 2020/06 | 月旦醫事法報告 |
| 2 | 藥品研發與近用──從藥事法專利連結專章及資料專屬權談起 Innovation and Access to Medicine: Implementation of Patent Linkage and Data Exclusivity in Taiwan |
李素華 | 2019/12 | 月旦醫事法報告 |
| 3 | 臺灣藥品專利訴訟之觀察──兼論專利連結制度的影響 Observation of Pharmaceutical Patent on Patent Infringement Litigation in Taiwan: Also on the Impact of the Patent Linkage System |
呂紹凡 | 2019/12 | 月旦醫事法報告 |
| 4 | 美國法下原開發藥廠與學名藥廠在藥品警告責任的競合與發展 The Concurrent Relationship between Brand Name and Generic Drug Manufacturer’s Duty to Warn under the US Law System |
李秉燊 | 2019/11 | 月旦醫事法報告 |
| 5 | 漫談藥品的分級、調劑與交付 Informal Discussing about the Rating System of Medicine, Disputing and Giving |
李志宏 | 2019/10 | 月旦醫事法報告 |
| 6 | 日本要指導醫藥品「面對面販售原則」抗告訴訟 Procedure of Appeal about Face-to-Face Trading of the Medicine with Instructions in Japan |
黃浥昕 | 2019/10 | 月旦醫事法報告 |
| 7 | 新藥查驗登記採藥品臨床使用證據之探討 Using “Real World Evidence” for New Drug Application in Taiwan |
鄭慧文、吳秉珊 | 2019/09 | 月旦醫事法報告 |
| 8 | 澳洲法院裁罰標示不實致誤導消費者的藥品製造商 Australian Courts Fine the Medicine Manufacturer of “Misleading Customers” Caused by Incorrectly Labeling |
劉依俐 | 2019/07 | 月旦醫事法報告 |
| 9 | 由現行法規正視管制藥品的安全與合理使用 Current Regulations of Controlled Substances: Use the Medication Safely and Appropriately |
陳奕志 | 2019/03 | 月旦醫事法報告 |
| 10 | 從止痛藥品使用不當案件鳥瞰臺灣對於麻醉藥品管制及使用規範 Look Down to the Regulations of the Control and the Use of Narcotic Drugs from Improper Use of Painkilling Drugs |
劉依俐 | 2019/03 | 月旦醫事法報告 |
